Cyclo Therapeutics, Inc. Annual Costs and Expenses in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cyclo Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
  • Cyclo Therapeutics, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $8.51M, a 62.8% increase year-over-year.
  • Cyclo Therapeutics, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $25.5M, a 26.7% increase year-over-year.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2023 was $21M, a 24.8% increase from 2022.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2022 was $16.9M, a 6.19% increase from 2021.
  • Cyclo Therapeutics, Inc. annual Costs and Expenses for 2021 was $15.9M, a 60.9% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $21M +$4.18M +24.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 $16.9M +$983K +6.19% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $15.9M +$6.01M +60.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-17
2020 $9.86M +$1.31M +15.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $8.55M +$3.27M +62% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $5.28M +$197K +3.88% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $5.08M -$628K -11% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
2016 $5.71M Jan 1, 2016 Dec 31, 2016 10-K 2018-04-16
2011 $1.11M +$292K +35.8% Jan 1, 2011 Dec 31, 2011 10-K 2012-03-16
2010 $814K Jan 1, 2010 Dec 31, 2010 10-K 2012-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.